November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
July 23, 2026 - 11:28
Efekta Education Appoints AI Veteran Matt Fisher as Chief Technology OfficerEfekta Education, a company known for its AI-driven learning technology, has appointed Matt Fisher as its new Chief Technology Officer. Fisher comes to the role with nearly two decades of...
July 22, 2026 - 17:09
A Look Back at Specialized Technology Stocks’ Q1 Earnings: Crane NXT (NYSE:CXT) Vs The Rest Of The PackThe first quarter earnings season has closed for the specialized technology sector, and the results paint a mixed picture of resilience and caution. Companies in this space, which provide niche...
July 22, 2026 - 05:27
International criminal groups use technology to expand in and beyond Asia, UN report saysSoutheast Asia-based criminal organizations are leveraging advanced technology and tightly integrated networks to create a booming underground economy that now stretches far beyond the region,...
July 21, 2026 - 06:05
Marvell Technology: The Stock Is Down 39% From Its High. Time to Buy the Dip? (NASDAQ: MRVL)Marvell Technology shares enjoyed a sharp climb in early June, fueled by optimism that was not directly tied to the company`s core business performance. That bullish wave has since lost its...